|
⚲
|
| Keyboard |
| Matthew Foy | |
|---|---|
| Firm | |
| Address | 3675 Market Street Suite 200 Philadelphia, PA 19104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Fore US Bio Inc | 021-546309 | Director | 37.4 M of 46.0 M |
||
| Fore US Bio Inc | 021-490554 | Director | 62.1 M of 122.6 M |
||
| SR One Capital Fund II-A LP | 021-413944 | Executive Officer | 83.5 M | ||
| ATOX Bio Inc | 021-307439 | Director | 33.0 M of 35.0 M |
||
| SR One Capital Management LP | |||||
| AMZL LP | 021-477879 | Executive Officer | 573.5 M | ||
| SR One Capital Opportunities Fund I LP | 021-477789 | Executive Officer | 236.6 M | ||
| SR One Capital Fund II Aggregator LP | 021-413516 | Executive Officer | 398.6 M | 672.3 M | |
| SR One Capital Fund I Aggregator LP | 021-375487 | Executive Officer | of 400.0 M |
460.1 M | |
| SR One Capital Fund I-A LP | 021-375486 | Executive Officer | of 400.0 M |
55.8 M | |
| SR One Capital Fund I-B LP | 021-375487 | Executive Officer | of 400.0 M |
439.1 M | |